Rate of treatment success and associated factors in the program for drug-susceptible tuberculosis in the Forest Region, Republic of Guinea, 2010-2017: A real-world retrospective observational cohort study

被引:2
|
作者
Schoenbaechler, Valerie [2 ]
Guilavogui, Yakpazouo [1 ]
Onivogui, Sosso [1 ]
Hebelamou, Jean [1 ]
Mugglin, Catrina [2 ]
Furrer, Hansjakob [2 ]
Henzen, Corina [2 ]
Bavogui, Esther Kolou [1 ]
Kolie, Cece [1 ]
Zoumanigui, Peve [1 ]
Beavogui, Ismael [1 ]
Leuenberger, David [1 ]
Staehelin, Cornelia [1 ,2 ]
机构
[1] Ctr Hosp Reg Specialise, Quartier Fassankoni, Commune Urbaine Macenta, Macenta, Region Forestie, Guinea
[2] Univ Bern, Bern Univ Hosp, Dept Infect Dis, Inselspital, Bern, Switzerland
关键词
Drug-susceptible tuberculosis; Sub-Saharan Africa; Republic of Guinea; End TB strategy; Treatment success rate; TB-HIV co-infection;
D O I
10.1016/j.ijid.2021.06.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To analyze the treatment success rate (TSR = sum of cured or treatment completed) in the tuberculosis (TB) program for drug-susceptible TB (DS-TB) at the "Centre Hospitalier Regional Specialise" in Macenta, Forest Region, Republic of Guinea. Methods: This cohort study included patients who started treatment for DS-TB between 2010 and 2017. Data collection was part of the documentation for the national TB program. Descriptive analysis was applied to determine the TSR in various patient groups. Further, logistic regression was performed to determine factors influencing the TSR in new and relapsed cases versus all other previously treated cases. A subgroup analysis for only microbiologically confirmed pulmonary TB was added. Results: The study included 3969 patients. The TSR increased from 68.3% in 2010 to 80.8% in 2017 (p < 0.001). Mortality (11.2%) mainly occurred in early treatment months, while loss to follow-up (5.9%) increased towards later treatment months. Risk factors for low TSR were advanced age, positive HIV status, long travel distances (>100 km) to the clinic, and late treatment refill. Conclusion: The TSR in the Forest Region of Guinea remained below the WHO goal of 90%. Reaching this target remains a challenge in rural areas with high early mortality and increased risk of loss to follow-up. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:6 / 14
页数:9
相关论文
共 4 条
  • [1] Drug-susceptible tuberculosis treatment success and associated factors in Ethiopia from 2005 to 2017: a systematic review and meta-analysis
    Seid, Mohammed Assen
    Ayalew, Mohammed Biset
    Muche, Esileman Abdela
    Gebreyohannes, Eyob Alemayehu
    Abegaz, Tadesse Melaku
    [J]. BMJ OPEN, 2018, 8 (09):
  • [2] Treatment success rate and associated factors among drug susceptible tuberculosis individuals in St. Kizito Hospital, Matany, Napak district, Karamoja region. A retrospective study
    Opito, Ronald
    Kwenya, Keneth
    Ssentongo, Saadick Mugerwa
    Kizito, Mark
    Alwedo, Susan
    Bakashaba, Baker
    Miya, Yunus
    Bukenya, Lameck
    Okwir, Eddy
    Onega, Lilian Angwech
    Kazibwe, Andrew
    Othieno, Emmanuel
    Kirya, Fred
    Olupot, Peter Olupot
    [J]. PLOS ONE, 2024, 19 (05):
  • [3] Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data
    Ki, Min Seo
    Jeong, Dawoon
    Kang, Hee-Yeon
    Choi, Hongjo
    Sohn, Hojoon
    Kang, Young Ae
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [4] Retrospective cohort study of real-world treatment patterns and overall survival in patients with chronic lymphocytic leukemia (CLL) diagnosed between 2010 to 2017 in Ontario, Canada.
    Hassan, Shazia
    Hurry, Manjusha
    Seung, Soo Jin
    Walton, Ryan
    Elnoursi, Ashlie
    Scheider, Krystin
    Edwin, Jonathan
    Wagner, Dennis
    Aw, Andrew Ta Wei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)